Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype
- PMID: 19748159
- DOI: 10.1016/j.neurobiolaging.2009.08.006
Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype
Abstract
Objective: To study CSF biomarkers amyloid-beta 1-42 (Aβ42) and total tau (tau) in relation to APOE genotype in their ability to predict progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD).
Methods: In 100 MCI patients CSF Aβ42, tau and APOE genotype were determined. At follow-up of 18 (13-24) months 58 patients remained non-progressive and 42 progressed to AD.
Results: Cox proportional hazards models showed an interaction between Aβ42 and APOE genotype (p<0.05). Stratification for APOE revealed HR (95% CI) for abnormal Aβ42 of 8.2 (2.1-31.9) for ε4 non-carriers, 3.9 (0.8-18.5) for heterozygotes and 0.3 (0.0-1.7) for homozygotes. Inversely, stratification for Aβ42 revealed that in patients with normal levels of Aβ42, ε4 homozygotes had a strongly increased risk of progression to AD with HR (95% CI) 20.8 (2.4-182.8). Tau and APOE independently predicted progression to AD.
Conclusions: Aβ42 was a stronger predictor of progression to AD in APOE ε4 non-carriers than in carriers. Furthermore, the risk of progression for ε4 homozygotes was very high, also in patients with normal levels of Aβ42.
Copyright © 2009 Elsevier Inc. All rights reserved.
Similar articles
-
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367
-
Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype.Neurology. 2020 Oct 27;95(17):e2378-e2388. doi: 10.1212/WNL.0000000000010629. Epub 2020 Aug 11. Neurology. 2020. PMID: 32788242
-
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.Dement Geriatr Cogn Disord. 2009;27(5):458-64. doi: 10.1159/000216841. Epub 2009 May 7. Dement Geriatr Cogn Disord. 2009. PMID: 19420940 Free PMC article.
-
Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies.J Neurol Neurosurg Psychiatry. 2016 May;87(5):476-84. doi: 10.1136/jnnp-2014-310095. Epub 2015 May 22. J Neurol Neurosurg Psychiatry. 2016. PMID: 26001840 Review.
-
The Relationship Between Sleep Disturbance and Apolipoprotein E ε4 in Adults With Mild Cognitive Impairment and Alzheimer's Disease Dementia: An Integrative Review.Biol Res Nurs. 2022 Jul;24(3):327-337. doi: 10.1177/10998004221081044. Epub 2022 Apr 19. Biol Res Nurs. 2022. PMID: 35439097 Review.
Cited by
-
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.Alzheimers Res Ther. 2015 Sep 17;7(1):59. doi: 10.1186/s13195-015-0142-1. Alzheimers Res Ther. 2015. PMID: 26383836 Free PMC article.
-
Cerebrospinal Fluid Neurofilaments Light-Chain Differentiate Patients Affected by Alzheimer's Disease with Different Rate of Progression (RoP): A Preliminary Study.Brain Sci. 2024 Sep 25;14(10):960. doi: 10.3390/brainsci14100960. Brain Sci. 2024. PMID: 39451975 Free PMC article.
-
A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer's Disease.Biomedicines. 2022 Jul 15;10(7):1713. doi: 10.3390/biomedicines10071713. Biomedicines. 2022. PMID: 35885018 Free PMC article. Review.
-
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2. Cochrane Database Syst Rev. 2017. PMID: 28328043 Free PMC article. Review.
-
Blood-based biomarkers of Alzheimer's disease: challenging but feasible.Biomark Med. 2010 Feb;4(1):65-79. doi: 10.2217/bmm.09.84. Biomark Med. 2010. PMID: 20387303 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
